Titel

Merkliste
1 Ergebnisse

Interim results from the CATNON trial (EORTC study 26053-22..:

van den Bent, Martin J ; Baumert, Brigitta ; Erridge, Sara C...
van den Bent , M J , Baumert , B , Erridge , S C , Vogelbaum , M A , Nowak , A K , Sanson , M , Brandes , A A , Clement , P M , Baurain , J F , Mason , W P , Wheeler , H , Chinot , O L , Gill , S , Griffin , M , Brachman , D G , Taal , W , Rudà , R , Weller , M , McBain , C , Reijneveld , J , Enting , R H , Weber , D C , Lesimple , T , Clenton , S , Gijtenbeek , A , Pascoe , S , Herrlinger , U , Hau , P , Dhermain , F , van Heuvel , I , Stupp , R , Aldape , K , Jenkins , R B , Dubbink , H J , Dinjens , W N M , Wesseling , P , Nuyens , S , Golfinopoulos , V , Gorlia , T , Wick , W & Kros , J M 2017 , ' Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma : A phase 3, randomised, open-label intergroup study ' , The Lancet , vol. 390 , no. 10103 , pp. 1645-1653 . https://doi.org/10.1016/S0140-6736(17)31442-3 ; ISSN:0140-6736. , 2017

Link: http://hdl.handle.net/11370/e0a08e12-2ea9-4561-be22-07..

RT Journal
T1 <Title>Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma:A phase 3, randomised, open-label intergroup study</Title>

UL https://suche.suub.uni-bremen.de/peid=base-ftunigroningenpu:oai:pure.rug.nl:publications_e0a08e12-2ea9-4561-be22-0764dde6546e&Exemplar=1&LAN=DE
				
A1 van den Bent, Martin J
A1 Baumert, Brigitta
A1 Erridge, Sara C
A1 Vogelbaum, Michael A
A1 Nowak, Anna K
A1 Sanson, Marc
A1 Brandes, Alba Ariela
A1 Clement, Paul M
A1 Baurain, Jean Francais
A1 Mason, Warren P
A1 Wheeler, Helen
A1 Chinot, Olivier L
A1 Gill, Sanjeev
A1 Griffin, Matthew
A1 Brachman, David G
A1 Taal, Walter
A1 Rudà, Roberta
A1 Weller, Michael
A1 McBain, Catherine
A1 Reijneveld, Jaap
A1 Enting, Roelien H
A1 Weber, Damien C
A1 Lesimple, Thierry
A1 Clenton, Susan
A1 Gijtenbeek, Anja
A1 Pascoe, Sarah
A1 Herrlinger, Ulrich
A1 Hau, Peter
A1 Dhermain, Frederic
A1 van Heuvel, Irene
A1 Stupp, Roger
A1 Aldape, Ken
A1 Jenkins, Robert B
A1 Dubbink, Hendrikus Jan
A1 Dinjens, Winand N M
A1 Wesseling, Pieter
A1 Nuyens, Sarah
A1 Golfinopoulos, Vassilis
A1 Gorlia, Thierry
A1 Wick, Wolfgang
A1 Kros, Johan M
YR 2017
K1 BRAIN-TUMOR GROUP
K1 LOW-GRADE GLIOMA
K1 EUROPEAN ORGANIZATION
K1 OLIGODENDROGLIAL TUMORS
K1 IDH2 MUTATIONS
K1 III TRIAL
K1 PROCARBAZINE
K1 VINCRISTINE
K1 GLIOBLASTOMA
K1 CHEMOTHERAPY
JF van den Bent , M J , Baumert , B , Erridge , S C , Vogelbaum , M A , Nowak , A K , Sanson , M , Brandes , A A , Clement , P M , Baurain , J F , Mason , W P , Wheeler , H , Chinot , O L , Gill , S , Griffin , M , Brachman , D G , Taal , W , Rudà , R , Weller , M , McBain , C , Reijneveld , J , Enting , R H , Weber , D C , Lesimple , T , Clenton , S , Gijtenbeek , A , Pascoe , S , Herrlinger , U , Hau , P , Dhermain , F , van Heuvel , I , Stupp , R , Aldape , K , Jenkins , R B , Dubbink , H J , Dinjens , W N M , Wesseling , P , Nuyens , S , Golfinopoulos , V , Gorlia , T , Wick , W & Kros , J M 2017 , ' Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma : A phase 3, randomised, open-label intergroup study ' , The Lancet , vol. 390 , no. 10103 , pp. 1645-1653 . https://doi.org/10.1016/S0140-6736(17)31442-3 ; ISSN:0140-6736
LK http://hdl.handle.net/11370/e0a08e12-2ea9-4561-be22-0764dde6546e
DO http://hdl.handle.net/11370/e0a08e12-2ea9-4561-be22-0764dde6546e
SF ELIB - SuUB Bremen

Export

RefWorks (nur Desktop-Version!)
Flow (Zuerst in Flow einloggen, dann importieren)